• S&P 500: 1,342.64
  • Change: -0.69%
$14.10 0.62 (+4.60%)
2/10/2012 4:00 PM

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)

CAPS Rating: 4 out of 5

A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options.

Current Price $14.10 Mkt Cap $750.09M
Open $13.52 P/E Ratio 24.40
Prev. Close $13.48 Div. (Yield) N/A (N/A)
Daily Range $13.52 - $14.20 Volume 1,892,411
52-Wk Range $6.42 - $16.00 Avg. Daily Vol. 0

News & Discussion Boards

Caps

How do you think SPPI will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

373 Outperform
10 Underperform
 

All-Star Players

55 Outperform
1 Underperform
 

Wall Street

6 Outperform
1 Underperform
 

Top SPPI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mdriver78 (27.26)
Submitted February 16, 2011

Perhaps the FDA will approve Fusilev for mCRC on or before April 29, 2011.With FDA approval and full reimbursement, it is believed that many doctors will gravitate towards Fusilev. Here's why:Reliability - Fusilev supplies should be sufficient to… More

3 Comments | Reply | Report this Post

zzlangerhans (99.27)
Submitted May 03, 2011

As expected, Spectrum's share price rose as much as 12% today on an expected FDA approval of Fusilev for colorectal cancer, which was already pretty much written into the share price. Spectrum at a 500M cap has two problems. The first is that… More

11 Comments | Reply | Report this Post
SPPI VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about SPPI.

Recs

0
Member Avatar weinbpa (48.00) Submitted: 2/3/2012 10:19:57 AM : Outperform Start Price: $14.33 SPPI Score: -1.67

Appears undervalued based on drugs approved in the pipeline. Also is a potential take over cadidiate

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar AugieAugster (< 20) Submitted: 1/24/2012 3:01:51 PM : Outperform Start Price: $15.25 SPPI Score: -9.83

Eoquin first and foremost is going to bring in $500M a year starting in 2013.

On top of that you have F and Z picking up significant steam and B, which looks to have positive results from it's trial.

Not to mention many other drugs in the pipeline.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar TMFBiologyFool (97.67) Submitted: 1/24/2012 2:33:16 PM : Outperform Start Price: $13.49 SPPI Score: +5.22

Zevalin is the key

Report this Post Add Comment | Reply | Permalink
View All 58 Pitches »

Leaderboard

Find the members with the highest scoring picks in SPPI.

Score Leader

jms75

jms75 (70.34) Score: +326.48

The Score Leader is the player with the highest score across all their picks in SPPI.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
jms75 70.34 11/12/2007 Outperform 5Y $3.33 +323.42% -3.06% +326.48 0 Comment
mdriver78 27.26 11/9/2007 1/18/2011 Outperform 3Y $3.42 +312.28% -4.18% +316.46 4 Comments
dough99999 33.92 8/6/2007 Outperform 1Y $3.56 +296.07% -1.92% +297.99 0 Comment
comccart 92.97 8/8/2007 Outperform 3M $3.76 +275.00% -4.70% +279.70 0 Comment
Megalomania < 20 7/26/2007 Outperform 1Y $3.94 +257.87% -5.82% +263.69 0 Comment
lazzzzar < 20 5/8/2009 Outperform 1Y $3.46 +307.51% +46.68% +260.84 0 Comment
stockman132 78.63 10/8/2007 Outperform 1Y $4.13 +241.40% -9.09% +250.50 0 Comment
skyyhi 69.21 5/8/2009 Outperform 1Y $3.55 +297.18% +47.66% +249.52 0 Comment
hudicek7 < 20 10/23/2007 Outperform 1Y $4.14 +240.58% -6.59% +247.17 0 Comment
LowPoints < 20 7/7/2010 Outperform 5Y $3.74 +277.01% +30.28% +246.72 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackAurigaUSA < 20 9/30/2011 Outperform NS $7.54 +87.00% +17.40% +69.61 0 Comment
trackmlvcapital 78.21 5/2/2011 Outperform NS $9.87 +42.80% -1.55% +44.35 0 Comment
TrackRBCCapMkts 93.36 3/25/2011 Outperform NS $8.49 +66.08% +2.38% +63.70 0 Comment
TrackJimCramer 78.17 3/25/2011 Underperform 3W $8.58 +64.34% +2.33% -62.00 0 Comment
TrackMorganJos 56.19 1/12/2010 Outperform NS $5.00 +182.00% +17.89% +164.11 0 Comment
TrackRodmanRen < 20 10/31/2007 Outperform NS $3.72 +279.03% -8.59% +287.62 0 Comment
TrackBreanMurray 65.65 10/9/2007 Outperform NS $4.35 -47.13% -15.96% -31.17 3/18/2008 @ $2.30 0 Comment
TrackLazardCapit 78.92 7/25/2007 Outperform NS $4.01 +251.62% -6.53% +258.16 0 Comment
TrackBreanMurray 65.65 7/24/2007 Underperform NS $4.92 -16.67% -1.26% +15.41 7/25/2007 @ $4.10 0 Comment
TrackFBRCapitalM 84.63 5/24/2007 Outperform NS $6.42 -36.14% -0.19% -35.95 7/25/2007 @ $4.10 0 Comment
TrackBreanMurray 65.65 4/11/2007 Outperform NS $6.85 -26.57% +6.87% -33.44 7/23/2007 @ $5.03 0 Comment
TrackOppenheimer 79.13 12/6/2006 Outperform NS $5.80 -72.07% -2.68% -69.39 4/23/2008 @ $1.62 0 Comment

Featured Broker Partners